{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:23:39Z","timestamp":1793157819042,"version":"4.5.0"},"reference-count":115,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010438","name":"Poznan University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010438","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine &amp; Growth Factor Reviews"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.cytogfr.2026.03.002","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T03:15:40Z","timestamp":1775099740000},"page":"15-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Chemokines in thyroid cancer: Mechanistic insights and clinical implications"],"prefix":"10.1016","volume":"89","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-5288-1577","authenticated-orcid":false,"given":"Aleksandra Wiktoria","family":"Bratborska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Rucha\u0142a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cytogfr.2026.03.002_bib1","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"issue":"11","key":"10.1016\/j.cytogfr.2026.03.002_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26115173","article-title":"Thyroid cancer: epidemiology, classification, risk factors, diagnostic and prognostic markers, and current treatment strategies","volume":"26","author":"Forma","year":"2025","journal-title":"Int J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.cytogfr.2026.03.002_bib3","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1089\/thy.2021.0662","article-title":"Thyroid cancer incidence and mortality trends in the United States: 2000-2018","volume":"32","author":"Megwalu","year":"2022","journal-title":"Thyroid"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.03.002_bib4","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/s41420-024-02157-2","article-title":"High aggressiveness of papillary thyroid cancer: from clinical evidence to regulatory cellular networks","volume":"10","author":"Zhang","year":"2024","journal-title":"Cell Death Discov."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.03.002_bib5","first-page":"38","article-title":"Thyroid carcinoma pattern presentation according to age","volume":"21","author":"Girardi","year":"2017","journal-title":"Int Arch. Otorhinolaryngol."},{"issue":"7","key":"10.1016\/j.cytogfr.2026.03.002_bib6","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/cncr.22956","article-title":"Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis","volume":"110","author":"Sampson","year":"2007","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.cytogfr.2026.03.002_bib7","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S2213-8587(22)00035-3","article-title":"The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020","volume":"10","author":"Pizzato","year":"2022","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"7","key":"10.1016\/j.cytogfr.2026.03.002_bib8","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1007\/s12325-020-01391-1","article-title":"Papillary thyroid cancer-aggressive variants and impact on management: a narrative review","volume":"37","author":"Coca-Pelaz","year":"2020","journal-title":"Adv. Ther."},{"issue":"16","key":"10.1016\/j.cytogfr.2026.03.002_bib9","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1111\/febs.14466","article-title":"A guide to chemokines and their receptors","volume":"285","author":"Hughes","year":"2018","journal-title":"FEBS J."},{"issue":"11","key":"10.1016\/j.cytogfr.2026.03.002_bib10","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1089\/thy.2016.0660","article-title":"The Role of Chemokines in Thyroid Carcinoma","volume":"27","author":"Yapa","year":"2017","journal-title":"Thyroid"},{"issue":"9","key":"10.1016\/j.cytogfr.2026.03.002_bib11","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nri.2017.49","article-title":"Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy","volume":"17","author":"Nagarsheth","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cytogfr.2026.03.002_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.724139","article-title":"Chemokines in progression, chemoresistance, diagnosis, and prognosis of colorectal cancer","volume":"13","author":"Zou","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.cytogfr.2026.03.002_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1443366","article-title":"Chemokines in the tumor microenvironment: implications for lung cancer and immunotherapy","volume":"15","author":"Jung","year":"2024","journal-title":"Front Immunol."},{"issue":"11","key":"10.1016\/j.cytogfr.2026.03.002_bib14","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1002\/cam4.3014","article-title":"Chemokines and chemokine receptors: A new strategy for breast cancer therapy","volume":"9","author":"Liu","year":"2020","journal-title":"Cancer Med"},{"issue":"16","key":"10.1016\/j.cytogfr.2026.03.002_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23168846","article-title":"Chemokines in Primary Liver Cancer","volume":"23","author":"Zajkowska","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.cytogfr.2026.03.002_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107213","article-title":"Pro-inflammatory cytokines and CXC chemokines as game-changer in age-associated prostate cancer and ovarian cancer: Insights from preclinical and clinical studies' outcomes","volume":"204","author":"Ullah","year":"2024","journal-title":"Pharm. Res"},{"issue":"2","key":"10.1016\/j.cytogfr.2026.03.002_bib17","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ceb.2009.01.013","article-title":"Role of MAPK pathway oncoproteins in thyroid cancer pathogenesis and as drug targets","volume":"21","author":"Knauf","year":"2009","journal-title":"Curr. Opin. Cell Biol."},{"issue":"6","key":"10.1016\/j.cytogfr.2026.03.002_bib18","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.21873\/anticanres.13397","article-title":"Clinical Significance of Selected Chemokines in Thyroid Cancer","volume":"39","author":"Mironska","year":"2019","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.03.002_bib19","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1210\/jc.2012-2555","article-title":"Interferon-\u03b3 and tumor necrosis factor-\u03b1 sustain secretion of specific CXC chemokines in human thyrocytes: a first step toward a differentiation between autoimmune and tumor-related inflammation?","volume":"98","author":"Rotondi","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cytogfr.2026.03.002_bib20","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3389\/fendo.2018.00314","article-title":"Role of Chemokines in Thyroid Cancer Microenvironment: Is CXCL8 the Main Player?","volume":"9","author":"Rotondi","year":"2018","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.cytogfr.2026.03.002_bib21","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cyto.2018.02.012","article-title":"Chemokines beyond chemo-attraction: CXCL10 and its significant role in cancer and autoimmunity","volume":"109","author":"Karin","year":"2018","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.03.002_bib22","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20203459","article-title":"CXCL10 is a potential biomarker and associated with immune infiltration in human papillary thyroid cancer","volume":"41","author":"Qin","year":"2021","journal-title":"Biosci. Rep."},{"issue":"2","key":"10.1016\/j.cytogfr.2026.03.002_bib23","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.18632\/oncotarget.23502","article-title":"Differential expression profile of CXCR3 splicing variants is associated with thyroid neoplasia. Potential role in papillary thyroid carcinoma oncogenesis?","volume":"9","author":"Urra","year":"2018","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.cytogfr.2026.03.002_bib24","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1677\/ERC-08-0337","article-title":"Dysregulation of secretion of CXC alpha-chemokine CXCL10 in papillary thyroid cancer: modulation by peroxisome proliferator-activated receptor-gamma agonists","volume":"16","author":"Antonelli","year":"2009","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.cytogfr.2026.03.002_bib25","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8512417","article-title":"Effect of Interferon-\u03b3 on the Basal and the TNF\u03b1-Stimulated Secretion of CXCL8 in Thyroid Cancer Cell Lines Bearing Either the RET\/PTC Rearrangement Or the BRAF V600e Mutation","volume":"2016","author":"Rotondi","year":"2016","journal-title":"Mediat. Inflamm."},{"issue":"3","key":"10.1016\/j.cytogfr.2026.03.002_bib26","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0002-9440(10)64951-6","article-title":"Papillary carcinoma of the thyroid: hepatocyte growth factor (HGF) stimulates tumor cells to release chemokines active in recruiting dendritic cells","volume":"156","author":"Scarpino","year":"2000","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.cytogfr.2026.03.002_bib27","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.cyto.2012.04.042","article-title":"Variable modulation by cytokines and thiazolidinediones of the prototype Th1 chemokine CXCL10 in anaplastic thyroid cancer","volume":"59","author":"Antonelli","year":"2012","journal-title":"Cytokine"},{"key":"10.1016\/j.cytogfr.2026.03.002_bib28","doi-asserted-by":"crossref","DOI":"10.1177\/10732748241241162","article-title":"The Role of CXCL11 and its Receptors in Cancer: Prospective but Challenging Clinical Targets","volume":"31","author":"Wang","year":"2024","journal-title":"Cancer Control"},{"issue":"6","key":"10.1016\/j.cytogfr.2026.03.002_bib29","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1007\/s12026-018-9056-x","article-title":"The paramount role of cytokines and chemokines in papillary thyroid cancer: a review and experimental results","volume":"66","author":"Fallahi","year":"2018","journal-title":"Immunol. Res"},{"issue":"3","key":"10.1016\/j.cytogfr.2026.03.002_bib30","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/s41416-021-01340-x","article-title":"The role of anlotinib-mediated EGFR blockade in a positive feedback loop of CXCL11-EGF-EGFR signalling in anaplastic thyroid cancer angiogenesis","volume":"125","author":"Liang","year":"2021","journal-title":"Br. J. Cancer"},{"issue":"11","key":"10.1016\/j.cytogfr.2026.03.002_bib31","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/s41419-019-1966-6","article-title":"CCL14 serves as a novel prognostic factor and tumor suppressor of HCC by modulating cell cycle and promoting apoptosis","volume":"10","author":"Zhu","year":"2019","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.03.002_bib32","doi-asserted-by":"crossref","first-page":"784","DOI":"10.18632\/aging.102656","article-title":"CCL14 is a prognostic biomarker and correlates with immune infiltrates in hepatocellular carcinoma","volume":"12","author":"Gu","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"6","key":"10.1016\/j.cytogfr.2026.03.002_bib33","first-page":"695","article-title":"Chemokine CCL14 affected the clinical outcome and correlated with immune infiltrates in thyroid carcinoma","volume":"38","author":"Zhang","year":"2023","journal-title":"Histol. Histopathol."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.03.002_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2010.10.011","article-title":"The role of the CXC chemokines platelet factor-4 (CXCL4\/PF-4) and its variant (CXCL4L1\/PF-4var) in inflammation, angiogenesis and cancer","volume":"22","author":"Vandercappellen","year":"2011","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.cytogfr.2026.03.002_bib35","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ctrv.2017.11.007","article-title":"CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation - A target for novel cancer therapy","volume":"63","author":"Tokunaga","year":"2018","journal-title":"Cancer Treat. Rev."},{"issue":"11","key":"10.1016\/j.cytogfr.2026.03.002_bib36","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.3109\/10428194.2016.1151511","article-title":"Monokine induced by interferon gamma (MIG\/CXCL9) is an independent prognostic factor in newly diagnosed myeloma","volume":"57","author":"Bolomsky","year":"2016","journal-title":"Leuk. Lymphoma"},{"issue":"15","key":"10.1016\/j.cytogfr.2026.03.002_bib37","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.7150\/ijms.63402","article-title":"Bioinformatics analysis identified shared differentially expressed genes as potential biomarkers for Hashimoto's thyroiditis-related papillary thyroid cancer","volume":"18","author":"Liu","year":"2021","journal-title":"Int J. Med Sci."},{"issue":"2","key":"10.1016\/j.cytogfr.2026.03.002_bib38","doi-asserted-by":"crossref","first-page":"E338","DOI":"10.1210\/jc.2013-2792","article-title":"RNA sequencing identifies multiple fusion transcripts, differentially expressed genes, and reduced expression of immune function genes in BRAF (V600E) mutant vs BRAF wild-type papillary thyroid carcinoma","volume":"99","author":"Smallridge","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.cytogfr.2026.03.002_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23020792","article-title":"Gene, Promoter, Regulation of Expression, mRNA Stability, Regulation of Activity in the Intercellular Space","volume":"23","author":"Korbecki","year":"2022","journal-title":"Int J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.03.002_bib40","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/stem.2492","article-title":"Interleukin-8, but not the Related Chemokine CXCL1, Sustains an Autocrine Circuit Necessary for the Properties and Functions of Thyroid Cancer Stem Cells","volume":"35","author":"Liotti","year":"2017","journal-title":"Stem Cells"},{"issue":"47","key":"10.1016\/j.cytogfr.2026.03.002_bib41","doi-asserted-by":"crossref","first-page":"6203","DOI":"10.1038\/onc.2010.348","article-title":"Mast cells have a protumorigenic role in human thyroid cancer","volume":"29","author":"Melillo","year":"2010","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.cytogfr.2026.03.002_bib42","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.4158\/EP171924.OR","article-title":"Long-term outcomes and prognostic factors in patients with differentiated thyroid cancer and distant metastases","volume":"23","author":"Hirsch","year":"2017","journal-title":"Endocr. Pr."},{"issue":"10","key":"10.1016\/j.cytogfr.2026.03.002_bib43","first-page":"2140","article-title":"Microarray expression profiling identifies genes, including cytokines, and biofunctions, as diapedesis, associated with a brain metastasis from a papillary thyroid carcinoma","volume":"6","author":"Schulten","year":"2016","journal-title":"Am. J. Cancer Res"},{"key":"10.1016\/j.cytogfr.2026.03.002_bib44","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1476-9255-5-3","article-title":"Inhibition of oncogene-induced inflammatory chemokines using a farnesyltransferase inhibitor","volume":"5","author":"Degeorge","year":"2008","journal-title":"J. Inflamm. (Lond. )"},{"issue":"2-3","key":"10.1016\/j.cytogfr.2026.03.002_bib45","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/cac2.12010","article-title":"CXCL5\/CXCR2 axis in tumor microenvironment as potential diagnostic biomarker and therapeutic target","volume":"40","author":"Zhang","year":"2020","journal-title":"Cancer Commun (Lond)"},{"issue":"5","key":"10.1016\/j.cytogfr.2026.03.002_bib46","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2022.2065837","article-title":"MicroRNA-873-5p suppresses cell malignant behaviors of thyroid cancer via targeting CXCL5 and regulating P53 pathway","volume":"18","author":"Chang","year":"2022","journal-title":"Hum. Vaccin Immunother."},{"issue":"17","key":"10.1016\/j.cytogfr.2026.03.002_bib47","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202405399","article-title":"CCL20\/CXCL5 drives crosstalk between anaplastic thyroid cancer stem cells and tumor-associated macrophages to promote tumor progression","volume":"12","author":"Liu","year":"2025","journal-title":"Adv. Sci."},{"issue":"9","key":"10.1016\/j.cytogfr.2026.03.002_bib48","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1089\/thy.2023.0427","article-title":"Macrophage-induced carboxypeptidase A4 promotes the progression of anaplastic thyroid cancer","volume":"34","author":"Choi","year":"2024","journal-title":"Thyroid"},{"issue":"6","key":"10.1016\/j.cytogfr.2026.03.002_bib49","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.ejca.2006.01.003","article-title":"Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy","volume":"42","author":"Sica","year":"2006","journal-title":"Eur. J. Cancer"},{"issue":"7","key":"10.1016\/j.cytogfr.2026.03.002_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022567","article-title":"Tumor-associated macrophages (TAMs) form an interconnected cellular supportive network in anaplastic thyroid carcinoma","volume":"6","author":"Caillou","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.cytogfr.2026.03.002_bib51","article-title":"CXCL5 expression is associated with active signals of macrophages in the microenvironment of papillary thyroid carcinoma","volume":"261","author":"Le","year":"2024","journal-title":"Pathol. Res Pr."},{"key":"10.1016\/j.cytogfr.2026.03.002_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biochi.2018.02.009","article-title":"Activated CXCL5-CXCR2 axis promotes the migration, invasion and EMT of papillary thyroid carcinoma cells via modulation of \u03b2-catenin pathway","volume":"148","author":"Cui","year":"2018","journal-title":"Biochimie"},{"issue":"5","key":"10.1016\/j.cytogfr.2026.03.002_bib53","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1080\/15384047.2018.1539289","article-title":"Activation of CXCL5-CXCR2 axis promotes proliferation and accelerates G1 to S phase transition of papillary thyroid carcinoma cells and activates JNK and p38 pathways","volume":"20","author":"Cui","year":"2019","journal-title":"Cancer Biol. Ther."},{"issue":"5","key":"10.1016\/j.cytogfr.2026.03.002_bib54","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/ijc.10116","article-title":"Establishment of a non-tumorigenic papillary thyroid cell line (FB-2) carrying the RET\/PTC1 rearrangement","volume":"97","author":"Basolo","year":"2002","journal-title":"Int J. Cancer"},{"issue":"40","key":"10.1016\/j.cytogfr.2026.03.002_bib55","doi-asserted-by":"crossref","first-page":"5175","DOI":"10.1038\/onc.2014.441","article-title":"Mast cells induce epithelial-to-mesenchymal transition and stem cell features in human thyroid cancer cells through an IL-8-Akt-Slug pathway","volume":"34","author":"Visciano","year":"2015","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.cytogfr.2026.03.002_bib56","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1365-2265.2009.03699.x","article-title":"The tight relationship between papillary thyroid cancer, autoimmunity and inflammation: clinical and molecular studies","volume":"72","author":"Muzza","year":"2010","journal-title":"Clin. Endocrinol. (Oxf. )"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.03.002_bib57","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s12020-015-0764-x","article-title":"Normal human thyroid cells, BCPAP, and TPC-1 thyroid tumor cell lines display different profile in both basal and TNF-\u03b1-induced CXCL8 secretion","volume":"54","author":"Coperchini","year":"2016","journal-title":"Endocrine"},{"issue":"41","key":"10.1016\/j.cytogfr.2026.03.002_bib58","doi-asserted-by":"crossref","first-page":"14825","DOI":"10.1073\/pnas.0503039102","article-title":"Induction of a proinflammatory program in normal human thyrocytes by the RET\/PTC1 oncogene","volume":"102","author":"Borrello","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.03.002_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1098-2264(199605)16:1<1::AID-GCC1>3.0.CO;2-4","article-title":"Cytogenetics and molecular genetics of carcinomas arising from thyroid epithelial follicular cells","volume":"16","author":"Pierotti","year":"1996","journal-title":"Genes Chromosomes Cancer"},{"issue":"8","key":"10.1016\/j.cytogfr.2026.03.002_bib60","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1093\/carcin\/bgu060","article-title":"Tumor-associated macrophages promote the metastatic potential of thyroid papillary cancer by releasing CXCL8","volume":"35","author":"Fang","year":"2014","journal-title":"Carcinogenesis"},{"issue":"3","key":"10.1016\/j.cytogfr.2026.03.002_bib61","first-page":"216","article-title":"Morphoproteomic confirmation of an activated nuclear factor-\u043aBp65 pathway in follicular thyroid carcinoma","volume":"5","author":"Liu","year":"2012","journal-title":"Int J. Clin. Exp. Pathol."},{"key":"10.1016\/j.cytogfr.2026.03.002_bib62","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/270149","article-title":"Clinical utility of serum interleukin-8 and interferon-alpha in thyroid diseases","volume":"2011","author":"Kobawala","year":"2011","journal-title":"J. Thyroid Res"},{"issue":"12","key":"10.1016\/j.cytogfr.2026.03.002_bib63","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1002\/prca.200780095","article-title":"Multiplex analysis of cytokines as biomarkers that differentiate benign and malignant thyroid diseases","volume":"2","author":"Linkov","year":"2008","journal-title":"Proteom. Clin. Appl."},{"issue":"7","key":"10.1016\/j.cytogfr.2026.03.002_bib64","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1158\/1078-0432.CCR-10-2041","article-title":"Identification of soluble candidate biomarkers of therapeutic response to sunitinib in medullary thyroid carcinoma in preclinical models","volume":"17","author":"Broutin","year":"2011","journal-title":"Clin. Cancer Res"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.03.002_bib65","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1158\/1078-0432.CCR-18-0663","article-title":"Aberrant Thyroid-Stimulating Hormone Receptor Signaling Increases VEGF-A and CXCL8 Secretion of Thyroid Cancer Cells, Contributing to Angiogenesis and Tumor Growth","volume":"25","author":"Song","year":"2019","journal-title":"Clin. Cancer Res"},{"issue":"23","key":"10.1016\/j.cytogfr.2026.03.002_bib66","doi-asserted-by":"crossref","first-page":"63522","DOI":"10.1007\/s11356-023-26797-6","article-title":"PFOA, PFHxA and C6O4 differently modulate the expression of CXCL8 in normal thyroid cells and in thyroid cancer cell lines","volume":"30","author":"Coperchini","year":"2023","journal-title":"Environ. Sci. Pollut. Res Int"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.03.002_bib67","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s40618-024-02410-6","article-title":"Selective anti-CXCR2 receptor blockade by AZD5069 inhibits CXCL8-mediated pro-tumorigenic activity in human thyroid cancer cells in vitro","volume":"48","author":"Coperchini","year":"2025","journal-title":"J. Endocrinol. Invest"},{"issue":"3","key":"10.1016\/j.cytogfr.2026.03.002_bib68","doi-asserted-by":"crossref","first-page":"E427","DOI":"10.1210\/jc.2014-3045","article-title":"Metformin reverts the secretion of CXCL8 induced by TNF-\u03b1 in primary cultures of human thyroid cells: an additional indirect anti-tumor effect of the drug","volume":"100","author":"Rotondi","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.cytogfr.2026.03.002_bib69","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s40618-018-0862-8","article-title":"The AMPK-activator AICAR in thyroid cancer: effects on CXCL8 secretion and on CXCL8-induced neoplastic cell migration","volume":"41","author":"Awwad","year":"2018","journal-title":"J. Endocrinol. Invest"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.03.002_bib70","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.1038\/s41598-019-40818-w","article-title":"The BRAF-inhibitor PLX4720 inhibits CXCL8 secretion in BRAFV600E mutated and normal thyroid cells: a further anti-cancer effect of BRAF-inhibitors","volume":"9","author":"Coperchini","year":"2019","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.cytogfr.2026.03.002_bib71","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.18632\/oncotarget.6430","article-title":"The oncolytic virus dl922-947 reduces IL-8\/CXCL8 and MCP-1\/CCL2 expression and impairs angiogenesis and macrophage infiltration in anaplastic thyroid carcinoma","volume":"7","author":"Passaro","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.cytogfr.2026.03.002_bib72","doi-asserted-by":"crossref","DOI":"10.1177\/09603271221111333","article-title":"Ursolic acid inhibits proliferation, migration and invasion of human papillary thyroid carcinoma cells via CXCL12\/CXCR4\/CXCR7 axis through cancer-associated fibroblasts","volume":"41","author":"Cao","year":"2022","journal-title":"Hum. Exp. Toxicol."},{"issue":"6","key":"10.1016\/j.cytogfr.2026.03.002_bib73","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.3892\/ijo.2016.3485","article-title":"Expression and function of CXCL12\/CXCR4\/CXCR7 in thyroid cancer","volume":"48","author":"Zhu","year":"2016","journal-title":"Int J. Oncol."},{"issue":"5","key":"10.1016\/j.cytogfr.2026.03.002_bib74","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1159\/000351305","article-title":"Application of chemokine CXC motif ligand 12 as a novel diagnostic marker in preoperative fine-needle aspiration biopsy for papillary thyroid carcinoma","volume":"57","author":"Jung","year":"2013","journal-title":"Acta Cytol."},{"issue":"7","key":"10.1016\/j.cytogfr.2026.03.002_bib75","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1002\/hed.23404","article-title":"CXC motif ligand 12 as a novel diagnostic marker for papillary thyroid carcinoma","volume":"36","author":"Chung","year":"2014","journal-title":"Head. Neck"},{"issue":"4","key":"10.1016\/j.cytogfr.2026.03.002_bib76","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s12022-012-9223-x","article-title":"Expression of stromal cell-derived factor 1 and CXCR7 in papillary thyroid carcinoma","volume":"23","author":"Liu","year":"2012","journal-title":"Endocr. Pathol."},{"issue":"3","key":"10.1016\/j.cytogfr.2026.03.002_bib77","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3233\/CBM-230230","article-title":"Diagnostic and prognostic utility of TROP-2, SLP-2, and CXCL12 expression in papillary thyroid carcinoma","volume":"39","author":"Attia","year":"2024","journal-title":"Cancer Biomark."},{"key":"10.1016\/j.cytogfr.2026.03.002_bib78","article-title":"CXCL12 methylation-mediated epigenetic regulation of gene expression in papillary thyroid carcinoma","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.cytogfr.2026.03.002_bib79","doi-asserted-by":"crossref","first-page":"544","DOI":"10.4103\/IJPM.IJPM_722_19","article-title":"The clinical usefulness of chemokine C-X-C Motif Ligand 12 as a diagnostic marker for Papillary Thyroid Carcinoma","volume":"63","author":"Lee","year":"2020","journal-title":"Indian J. Pathol. Microbiol"},{"issue":"10","key":"10.1016\/j.cytogfr.2026.03.002_bib80","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa366","article-title":"Chaperone-mediated Autophagy Governs Progression of Papillary Thyroid Carcinoma via PPAR\u03b3-SDF1\/CXCR4 Signaling","volume":"105","author":"Zhou","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"35","key":"10.1016\/j.cytogfr.2026.03.002_bib81","doi-asserted-by":"crossref","first-page":"5958","DOI":"10.1038\/sj.onc.1207790","article-title":"Functional expression of the CXCR4 chemokine receptor is induced by RET\/PTC oncogenes and is a common event in human papillary thyroid carcinomas","volume":"23","author":"Castellone","year":"2004","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.cytogfr.2026.03.002_bib82","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3727\/096504018X15426763753594","article-title":"MicroRNA-101 Targets CXCL12-Mediated Akt and Snail Signaling Pathways to Inhibit Cellular Proliferation and Invasion in Papillary Thyroid Carcinoma","volume":"27","author":"Chen","year":"2019","journal-title":"Oncol. Res"},{"issue":"2","key":"10.1016\/j.cytogfr.2026.03.002_bib83","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/med.21379","article-title":"Direct Activation of Bax Protein for Cancer Therapy","volume":"36","author":"Liu","year":"2016","journal-title":"Med Res Rev."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.03.002_bib84","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1186\/s12935-021-02344-6","article-title":"E-cadherin on epithelial-mesenchymal transition in thyroid cancer","volume":"21","author":"Zhu","year":"2021","journal-title":"Cancer Cell Int"},{"issue":"6","key":"10.1016\/j.cytogfr.2026.03.002_bib85","first-page":"6670","article-title":"Identification of potential pathogenic candidates or diagnostic biomarkers in papillary thyroid carcinoma using expression and methylation profiles","volume":"18","author":"Wei","year":"2019","journal-title":"Oncol. Lett."},{"issue":"6","key":"10.1016\/j.cytogfr.2026.03.002_bib86","doi-asserted-by":"crossref","first-page":"929","DOI":"10.7150\/jca.23042","article-title":"CXCR4\/CXCR7\/CXCL12-Axis in Follicular Thyroid Carcinoma","volume":"9","author":"Werner","year":"2018","journal-title":"J. Cancer"},{"issue":"12","key":"10.1016\/j.cytogfr.2026.03.002_bib87","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1038\/bjc.2017.364","article-title":"CXCR4\/CXCR7\/CXCL12 axis promotes an invasive phenotype in medullary thyroid carcinoma","volume":"117","author":"Werner","year":"2017","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.03.002_bib88","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/s12902-022-01204-2","article-title":"The prognostic significance of CXCR4 and SDF-1 in differentiated thyroid cancer depends on CD8+ density","volume":"22","author":"Wilhelm","year":"2022","journal-title":"BMC Endocr. Disord."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.03.002_bib89","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s13046-021-01964-0","article-title":"circPVT1 regulates medullary thyroid cancer growth and metastasis by targeting miR-455-5p to activate CXCL12\/CXCR4 signaling","volume":"40","author":"Zheng","year":"2021","journal-title":"J. Exp. Clin. Cancer Res"},{"issue":"19","key":"10.1016\/j.cytogfr.2026.03.002_bib90","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13194985","article-title":"Vimentin Is at the Heart of Epithelial Mesenchymal Transition (EMT) Mediated Metastasis","volume":"13","author":"Usman","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10.1016\/j.cytogfr.2026.03.002_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101208","article-title":"FGF9\/FGFR1 promotes cell proliferation, epithelial-mesenchymal transition, M2 macrophage infiltration and liver metastasis of lung cancer","volume":"14","author":"Chang","year":"2021","journal-title":"Transl. Oncol."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.03.002_bib92","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3892\/ijo.2016.3521","article-title":"Two E-selectin ligands, BST-2 and LGALS3BP, predict metastasis and poor survival of ER-negative breast cancer","volume":"49","author":"Woodman","year":"2016","journal-title":"Int J. Oncol."},{"issue":"11","key":"10.1016\/j.cytogfr.2026.03.002_bib93","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202356902","article-title":"Molecular mechanisms of TWIST1-regulated transcription in EMT and cancer metastasis","volume":"24","author":"Yu","year":"2023","journal-title":"EMBO Rep."},{"issue":"20","key":"10.1016\/j.cytogfr.2026.03.002_bib94","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222011062","article-title":"Epigenetic Regulation and Post-Translational Modifications of SNAI1 in Cancer Metastasis","volume":"22","author":"Dong","year":"2021","journal-title":"Int J. Mol. Sci."},{"issue":"35","key":"10.1016\/j.cytogfr.2026.03.002_bib95","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1038\/s41388-018-0304-2","article-title":"E-cadherin in contact inhibition and cancer","volume":"37","author":"Mendonsa","year":"2018","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.cytogfr.2026.03.002_bib96","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1530\/ERC-15-0196","article-title":"CXCL16 signaling mediated macrophage effects on tumor invasion of papillary thyroid carcinoma","volume":"23","author":"Cho","year":"2016","journal-title":"Endocr. Relat. Cancer"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.03.002_bib97","article-title":"CXCL16 positively correlated with M2-macrophage infiltration, enhanced angiogenesis, and poor prognosis in thyroid cancer","volume":"9","author":"Kim","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.03.002_bib98","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12964-020-00589-8","article-title":"CCL2\/CCR2 signaling in cancer pathogenesis","volume":"18","author":"Hao","year":"2020","journal-title":"Cell Commun. Signal"},{"issue":"3","key":"10.1016\/j.cytogfr.2026.03.002_bib99","doi-asserted-by":"crossref","first-page":"458","DOI":"10.2174\/1871520617666170719152349","article-title":"CCL2 is Modulated by Cytokines and PPAR-\u03b3 in Anaplastic Thyroid Cancer","volume":"18","author":"Ferrari","year":"2018","journal-title":"Anticancer Agents Med Chem."},{"issue":"5","key":"10.1016\/j.cytogfr.2026.03.002_bib100","doi-asserted-by":"crossref","first-page":"780","DOI":"10.3892\/ol.2021.13041","article-title":"Identification of soluble tissue-derived biomarkers from human thyroid tissue explants maintained on a microfluidic device","volume":"22","author":"Riley","year":"2021","journal-title":"Oncol. Lett."},{"issue":"21","key":"10.1016\/j.cytogfr.2026.03.002_bib101","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21218412","article-title":"CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of the Ligands of Receptors CCR1, CCR2, CCR3, and CCR4","volume":"21","author":"Korbecki","year":"2020","journal-title":"Int J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.03.002_bib102","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-75750-1","article-title":"The expression of CCL17 and potential prognostic value on tumor immunity in thyroid carcinoma based on bioinformatics analysis","volume":"14","author":"Gu","year":"2024","journal-title":"Sci. Rep."},{"issue":"15","key":"10.1016\/j.cytogfr.2026.03.002_bib103","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21155186","article-title":"The CCL20-CCR6 Axis in Cancer Progression","volume":"21","author":"Kadomoto","year":"2020","journal-title":"Int J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.03.002_bib104","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.yexmp.2014.06.012","article-title":"CCL20\/CCR6 promotes the invasion and migration of thyroid cancer cells via NF-kappa B signaling-induced MMP-3 production","volume":"97","author":"Zeng","year":"2014","journal-title":"Exp. Mol. Pathol."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.03.002_bib105","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12935-025-03765-3","article-title":"CXCL2: a key player in the tumor microenvironment and inflammatory diseases","volume":"25","author":"Lv","year":"2025","journal-title":"Cancer Cell Int"},{"issue":"8","key":"10.1016\/j.cytogfr.2026.03.002_bib106","doi-asserted-by":"crossref","first-page":"4413","DOI":"10.1007\/s10238-023-01152-8","article-title":"CXCL6: A potential therapeutic target for inflammation and cancer","volume":"23","author":"Dai","year":"2023","journal-title":"Clin. Exp. Med"},{"issue":"3","key":"10.1016\/j.cytogfr.2026.03.002_bib107","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.3390\/curroncol30030200","article-title":"Tumor-Infiltrating Immune Cell Landscapes in the Lymph Node Metastasis of Papillary Thyroid Cancer","volume":"30","author":"Amanullah","year":"2023","journal-title":"Curr. Oncol."},{"issue":"15","key":"10.1016\/j.cytogfr.2026.03.002_bib108","doi-asserted-by":"crossref","first-page":"4735","DOI":"10.1158\/1078-0432.CCR-07-4372","article-title":"Gene expression profiling of papillary thyroid carcinoma identifies transcripts correlated with BRAF mutational status and lymph node metastasis","volume":"14","author":"Oler","year":"2008","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.cytogfr.2026.03.002_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2019.109363","article-title":"Platelet-secreted CCL3 and its receptor CCR5 promote invasive and migratory abilities of anaplastic thyroid carcinoma cells via MMP-1","volume":"63","author":"Wang","year":"2019","journal-title":"Cell Signal"},{"issue":"6","key":"10.1016\/j.cytogfr.2026.03.002_bib110","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3109\/08941939.2013.805857","article-title":"Association study of chemokine (C-C motif) ligand 5 gene polymorphism and papillary thyroid cancer","volume":"26","author":"Kwon","year":"2013","journal-title":"J. Invest Surg."},{"key":"10.1016\/j.cytogfr.2026.03.002_bib111","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12885-016-2114-7","article-title":"Follicular thyroid carcinoma but not adenoma recruits tumor-associated macrophages by releasing CCL15","volume":"16","author":"Huang","year":"2016","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.03.002_bib112","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","article-title":"Macrophage diversity enhances tumor progression and metastasis","volume":"141","author":"Qian","year":"2010","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.cytogfr.2026.03.002_bib113","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.3892\/mmr.2016.5686","article-title":"Iodine regulates G2\/M progression induced by CCL21\/CCR7 interaction in primary cultures of papillary thyroid cancer cells with RET\/PTC expression","volume":"14","author":"Zhang","year":"2016","journal-title":"Mol. Med Rep."},{"issue":"12","key":"10.1016\/j.cytogfr.2026.03.002_bib114","doi-asserted-by":"crossref","DOI":"10.1177\/03000605221139555","article-title":"CCL22 and CCL26 are potential biomarkers for predicting distant metastasis in thyroid carcinoma","volume":"50","author":"Tong","year":"2022","journal-title":"J. Int Med Res"},{"issue":"10","key":"10.1016\/j.cytogfr.2026.03.002_bib115","first-page":"1189","article-title":"Increased expression of CX3CL1 and CX3CR1 in papillary thyroid carcinoma","volume":"35","author":"Wu","year":"2020","journal-title":"Histol. Histopathol."}],"container-title":["Cytokine &amp; Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610126000298?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610126000298?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T11:32:08Z","timestamp":1778326328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359610126000298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":115,"alternative-id":["S1359610126000298"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2026.03.002","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemokines in thyroid cancer: Mechanistic insights and clinical implications","name":"articletitle","label":"Article Title"},{"value":"Cytokine & Growth Factor Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cytogfr.2026.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}